How We Drive Key Outcomes

Our goal from the beginning has been to make rapid progress in the fight against IPF and other interstitial lung diseases. Thanks to the commitment of our corporate and academic partners we are well on the way. OSIC has sourced images and clinical data for the repository from a variety of sources: academic and pharmaceutical companies, and is seeking help from governmental agencies, patient advocacy groups and, through direct outreach, from patients.​

2022 GOAL

15,000 anonymized scans with accompanying clinical data

COMMITTED TO DATE

16,342 anonymized scans with accompanying clinical data